Abstract
A series of bivalent ligands (2-8) derived from 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine methiodide 1 has been synthesized and tested to evaluate affinity and selectivity for M1, M2 and M3 muscarinic receptor subtypes. In order to study the contribution of the spacer and of a second cationic head to the binding process, unsymmetrical ligands (9,10) have also been prepared. The results, expressed in terms of pA2 values, show that, although the spacer negatively affects the interaction of the bivalent ligands with the three receptor subtypes, affinity and selectivity are modulated by its length; this indicates that the pharmacophore binding sites are organized differently with respect to their mutual proximity and orientation, in each receptor subtype.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / antagonists & inhibitors
-
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / pharmacology
-
Animals
-
Atrial Function
-
Carbachol / pharmacology
-
Dioxolanes / chemical synthesis*
-
Dioxolanes / pharmacokinetics
-
Dioxolanes / pharmacology
-
Electric Stimulation
-
Guinea Pigs
-
Heart Atria / drug effects
-
Ileum / drug effects
-
In Vitro Techniques
-
Isometric Contraction / drug effects
-
Ligands
-
Male
-
Muscle Contraction / drug effects
-
Muscle, Smooth / drug effects
-
Myocardial Contraction / drug effects
-
Parasympatholytics / chemical synthesis*
-
Parasympatholytics / pharmacokinetics
-
Parasympatholytics / pharmacology
-
Rabbits
-
Receptors, Muscarinic / metabolism*
-
Vas Deferens / drug effects
Substances
-
2,2-diphenyl-(1,3)-dioxolan-4-ylmethyl(dimethyl)amine methiodide
-
Dioxolanes
-
Ligands
-
Parasympatholytics
-
Receptors, Muscarinic
-
(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride
-
Carbachol